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Abstract-Intracellular recordings were performed on hippocampal CA3 neurons in vitro to investigate 
the inhibitory tonus generated by endogenously produced adenosine in this brain region. Bath application 
of the highly selective adenosine A, receptor antagonist 1,3-dipropyL8cyclopentylxanthine at concen- 
trations up to 100 nM induced both spontaneous and stimulus-evoked epileptiform burst discharges. Once 
induced, the 1,3-dipropyl-8cyclopentylxanthine-evoked pileptiform activity was apparently irreversible 
even after prolonged superfusion with drug-free solution. The blockade of glutamatergic excitatory 
synaptic transmission by preincubation of the slices with the amino-3-hydroxy-5-methyl-4-isoxazolpropi- 
onic acid receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (10 PM), but not with the N-methyl-D- 
aspartate receptor antagonist o-2-amino-S-phosphonovaleric acid (50 PM), prevented the induction of 
epileptiform activity by 1,3-dipropyl-8-cyclopentylxanthine. The generation of the burst discharges was 
independent of the membrane potential, and the amplitude of the slow component of the paroxysmal 
depolarization shift increased with hyperpolarization, indicating that the 1,3-dipropyl-8-cyclopentylxan- 
thine-induced bursts were synaptically mediated events. Recordings from tetrodotoxin-treated CA3 
neurons revealed a strong postsynaptic component of endogenous adenosinergic inhibition. Both 
1,3-dipropyl-8-cyclopentylxanthine and the adenosine-degrading enzyme adenosine deaminase produced 
an apparently irreversible depolarization of the membrane potential by about 20 mV. Sometimes, this 
depolarization attained the threshold for the generation of putative calcium spikes, but no potential 
changes resembling paroxysmal depolarization shift-like events were observed. 
At the concentrations used in electrophysiological experiments (3&100 nM), 1,3-dipropyl-8- 
cyclopentylxanthine displayed only a negligible inhibitory action on total cyclic nucleotide phosphodiester- 
ase activity measured by means of a radiochemical assay in a homogenate of the rat cerebra1 cortex. 
Furthermore, even high concentrations of the selective phosphodiesterase inhibitor rolipram (10 PM), 
which displays no affinity to adenosine receptors, did not mimic the electrophysiologica.1 actions of 
1,3-dipropyl-8-cyclopentylxanthine, thus excluding the possibility that the effects of the A, receptor 
antagonist on neuronal discharge behavior can be ascribed to an inhibition of phosphodiesterases. 
The present data demonstrate that endogenously released adenosine exerts a vigorous control on the 
excitability of hippocampal CA3 neurons on both the pre- and postsynaptic sites. The long-lasting 
disinhibition following a transient suppression f adenosinergic inhibition strongly suggests hat, besides 
its well-known short-term effects on neuronal activity, adenosine might also contribute to the long-term 
control of hippocampal excitability. 
It is now generally accepted that a significant amount 
of endogenous adenosine is permanently present in 
the extracellular space of the mammalian 
CNS.‘7-‘9,36,43,44,48 Measurements in vivo and in vitro 
revealed basal levels of adenosine in the cerebrospinal 
fluid ranging from 1 to 5 ,uM.22~56 At these con- 
centrations, adenosine is capable of reducing trans- 
mitter releaseB and decreasing postsynaptic 
excitabi1ity.23.24,26 Electrophysiological studies have 
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adenosine deaminase; CNQX, 6-cyano-7-nitroquinoxa- 
line-2.3-dione: D-APV, o-2-amino-5-phosphonovaleric 
acid; DPCPX, 1>3-dipropyl-8-cyciopentylxanthine; 
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field EPSP; IBMX, 3-isobutyl-I-methylxanthine; 
NMDA, N-methyl-D-aspartate; PDS, paroxysmal de- 
polarization shift; TTX, tetrodotoxin. 
shown that adenosine exerts a potent short-term 
control on hippocampal excitability. Rises in extra- 
cellular adenosine produce a rapid depression of 
neuronal activity that is quickly reversible when 
adenosine levels return to base1ine.‘,2,23,24,4* While the 
immediate actions of adenosine are well established, 
some preliminary data from our and other labora- 
tories suggest hat adenosine might also contribute to 
the long-term control of neuronal excitability.3,4,6,51 In 
these studies, both a transient increase in extracellular 
adenosine as well as a transient removal of the 
adenosine tonus have been tentatively linked to long- 
lasting changes of hippocampal responsiveness. The 
present study aims to elaborate on this putative new 
role for adenosine. 
Adenosine exerts its actions on CNS neurons via 
two receptor subtypes, the A, and A, receptors.“,55 
The adenosine receptors can be blocked by xanthines 
such as caffeine and theophylline. Therefore, it has 
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been suggested that the well-known excitatory effects 
of these xanthines observed both in ~iz.0~~ and 
in oitro8~20~25~‘8 are due to their antagonistic action at 
adenosine receptors. However, these xanthine deriva- 
tives do not discriminate between A, and A, recep- 
tors.16 In addition, they also interfere with 
mechanisms not related to adenosinergic actions, e.g. 
inhibition of phosphodiesterases.” Consequently, 
these antagonists cannot be used as selective tools to 
investigate the extent and mechanisms of the en- 
dogenous adenosinergic tonus. 
The development of a highly selective adenosine A, 
receptor antagonist, 1,3-dipropyl%cyclopentylxan- 
thine (DPCPX).‘4.34 provided the possibility to study 
the actions produced by endogenously released 
adenosine via adenosine A, receptors. Using DPCPX, 
we have recently demonstrated that, in hippocampal 
slices, the excitability of area CA3 neurons is con- 
trolled by an A, receptor-mediated adenosine tonus 
which appeared to be equally potent to that exerted 
by GABA via the GABA, receptor.4 Most intrigu- 
ingly, a transient application of bPCPX was suffi- 
cient to cause sustained epileptiform activity. Since a 
concomitant action of DPCPX at the same adenosine 
receptor, namely the suppression of an adenosine- 
evoked K-current, was completely reversible in the 
same slices that displayed sustained epileptiform ac- 
tivity,4 the DPCPX-induced long-term changes in 
excitability cannot be ascribed to an irreversible 
blockade by DPCPX of A, receptors or a persistence 
of the drug in the tissue. This notion was supported 
by a recent quantitative pharmacological study show- 
ing that the actions of DPCPX in hippocampus are 
due to a competitive inhibition of A, receptors, the 
apparent dissociation constant (QJ being 3.3 nM.’ 
The role of presynaptically vs postsynaptically 
located A, receptors in the modulation of hippocam- 
pal excitability is still controversial. For example, it 
has been reported that the non-selective adenosine 
receptor antagonist caffeine induces epileptiform dis- 
charges in guinea-pig hippocampal CA3 neurons 
solely by postsynaptic mechanisms.38 On the other 
hand, intracellular recordings from neurons in an 
organotypic hippocampal culture provided evidence 
that adenosine antagonists enhance the presynaptic 
release of glutamate, leading to an increase in fre- 
quency and size of spontaneous excitatory post- 
synaptic potentials (EPSPS).~’ Furthermore, these 
antagonists facilitate the potassium-stimulated and 
basal release of glutamate from cerebellar granule 
cells in culture.40 The present study was designed to 
assess the contribution of pre- and/or postsynaptic 
elements to the generation of DPCPX-induced epilep- 
tiform activity. 
As a xanthine derivative, DPCPX may display 
some inhibitory action on brain phosphodiester- 
ases.4s,46 Since inhibition of CAMP phosphodiester- 
ases can enhance hippocampal excitability and 
sometimes, especially upon application of 3-isobutyl- 
1 -methylxanthine (IBMX), induce epileptiform ac- 
tivity,” we determined the actions of DPCPX on total 
phosphodiesterase activity in a homogenate from rat 
cerebral cortex by means of a radiochemlcal assay. 
To our knowledge, there is no evidence for a differen- 
tial distribution of brain phosphodiesterase isozymes 
between cortex and hippocampus. We also compared 
the effects of the selective CAMP phosphodiesterase 
inhibitor rolipram” on evoked field potentials 
recorded extracellularly in stratum radiatum of area 
CA3 to those induced by DPCPX. 
EXPERIMENTAL PROCEDURES 
Preparation and maintenance of slices 
Experiments were performed on slices obtained from the 
guinea-pig hippocampus. The procedure of slice preparation 
was essentially the same as described previously.‘4 In brief, 
the animals (180-300 g; source: Savo, D-88350 Kieslegg, 
Germany) were anesthetized with ether and decapitated. 
Following removal of the brain, the hippocampi were 
dissected and cut into two halves. Transverse slices of a 
nominal thickness of 500 pm were prepared by means of a 
Vibratome and stored in a holding chamber at room 
temperature for at least 90 min. Then, single slices were 
transferred to the recording chamber, where they were fixed 
between two nylon meshes: The slices were kepi submerged 
in artificial cerebrospinal fluid (ACSF) consisting of (in 
mM): NaCl 125, KC1 3, &Cl2 2, MgCl, 1.3, NaHCO, 25, 
NaH,PO, 1.25 and D-elucose 10. The solution was continu- i . 
ously gassed with a mixture of 95% 0, and 5% CO, in order 
to obtain a pH value of 7.4 at a recording temperature of 
31-32°C. 
Electrophysiology 
Intracellular recordings from CA3 pyramidal neurons 
were performed using glass microelectrodes filled with 3 M 
KCl. The resistance of these electrodes ranged between 30 
and 80 MR. Evoked field potentials were recorded from 
stratum radiatum of area CA3 by means of microelectrodes 
filled with 3 M NaCl (24 Ma). All signals were recorded 
and amplified using an npi SEC 1L amplifier (npi, Tamm, 
Germany). For voltage recordings and current injection, the 
amplifier was operated in the active bridge mode. Through- 
out the experiment, membrane potential was monitored on 
a chart recorder (Gould System Instruments, Cleveland, 
OH, U.S.A.) and stored on magnetic tape (TEAC MR30, 
Tokyo, Japan, frequency response d.c. - 2.5 kHz). To moni- 
tor the cells’ input resistances, hyperpolarizing current 
pulses (0.2 nA, 500 ms) were injected at a frequency of 
0.14.2 Hz. Synaptic potentials were elicited by means of a 
concentric bipolar electrode positioned in the mossy fiber 
pathway. Stimulation was performed at a frequency of 
0.05 Hz, and the duration of the stimulus was 50 ps. Neur- 
ons were selected on the basis of their resting membrane 
potentials (> - 60 mV), their input resistances (>70 MO) 
and their spike overshoots (> 15 mV). Intra- and extracellu- 
lar signals were digitized (sampling rate ~2 kHz) by means 
of a laboratory computer system (CED 1401, Cambridge, 
U.K. in conjunction with a PC AT) and stored for off-line 
analysis. Field potentials were averaged on-line (four to five 
sweeps). 
Application of drugs 
Drugs used in electrophysiological experiments were 
tetrodotoxin (TTX; Serva, Heidelberg, Germany), DPCPX 
(RBI, Natick, U.S.A.), adenosine deaminase (ADA; 
Boehringer Mannheim, Germany), 4-(3-cyclopentyloxy-4- 
methoxy-phenyl)-2-pyrrolidone (rolipram; Schering, Berlin, 
Germany). 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) 
and D-2-amino-5-phosphonovalerate (D-APV; both from 
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Tocris Neuramin, Buckhurst Hill, U.K.). The xanthines, 
rolipram and CNQX were taken from stock solutions 
(10 mM, dissolved in dimethylsulfoxide) and added to the 
ACSF to reach the final concentrations desired. The maxi- 
mum solvent concentration never exceeded 0.1%. At this 
concentration, dimethylsulfoxide neither affected the elec- 
trophysiological properties of CA3 neurons nor the ampli- 
tude and rise time of the extracellularly recorded field EPSP 
(fEPSP). All drugs were applied by addition to the ACSF, 
which was continuously circulated at a flow rate of 
3-5 mlimin. 
Measurement of phosphodiesterase activity 
Rat cerebral cortices were isolated and homogenized in 10 
volumes of buffer containing (in mM): BisTris 20, dithio- 
threitol 5, phenylmethanesulfonylfluoride 0.05, benzamidine 
2, EDTA 2, sodium acetate 50, pH 6.5. Genapol (O.lS%, 
v/v) was included to facilitate extraction of membrane 
bound phosphodiesterases. 39The homogenate was sonicated 
four times for 20 s a! 65 W and then centrifuaed for 20 min 
at 39,000g and 4°C. The supernatants were diluted with 
buffer consisting of 20 mM BisTris, 5 mM dithiothreitol and 
50mM sodium acetate (pH 6.5) to reach final protein 
concentrations of 0.4-0.5 mg/ml. 
Phosphodiesterase activity was assayed according to a 
radiochemical method initially described by Thompson 
ef a1.r’ and modified by Bauer and Schwabe. In a first step, 
‘H-labeled adenosine-3’,5’-monophosphate (f)H]cAMP) 
was hydrolysed to [3H]5’-adenosinemonophospbatee([3H]5’: 
AMP). In the second step, 13H]5’-AMP was degraded to 
[3H]adenosine by snake vendm I’-nucleotidase. Then, the 
product was separated from unconverted [rH]cAMP using 
anion-exchange chromatography. 
The incubation medium contained 50mM Tris-HCI 
(pH 8.0), 10 mM MgCl,, 4mM 2-mercaptoethanol, 
0.125 ma/ml bovine serum albumin. 100.000 c.n.m. ore- 
purified- [‘H&AMP (Amersham-Buchler, Braunschweig, 
Germanv: 20-30 Ciimmol) and 1 DM or 100 rrM CAMP. 
After a-3 min preincubarion at 3OC, the reaction was 
started by addition of 100 ~1 of homogenate. The incubation 
was performed at 30°C for 10min and the reaction was 
stopped by transferring the assay tubes to a water bath at 
90°C. After re-equilibration to room temperature, an excess 
of 5’-nucleotidase (snake venom from Ophrophagus hannah, 
I mg/ml) was added to each tube and the samples were 
incubated again at 30°C for 10min. This reaction was 
terminated by applying an aliquot of 0.2 ml to a QAE A-25 
Sephadex column (7 x 15 mm in Pasteur pipettes) pre- 
viously equilibrated with 3 ml of 30 mM ammonium for- 
mate (adjusted to pH 6 with formic acidj. The eluate was 
collected directly into scintillation vials. The columns were 
washed with 2ml ammonium formate buffer and these 
eluates were collected into the same vials. Radioactivity was 
measured by determination of c.p.m. in 15 ml of a scintil- 
lation fluid for aqueous samples (“Ready value”, Beckman, 
Munich, Germany). Assay blanks were prepared with either 
no or heat-inactivated homogenate. Recovery was deter- 
mined from samples containing 10 pg of commercial phos- 
phodiesterase (Boehringer Mannheim, Germany). The 
xanthine derivatives and rolipram were dissolved in 
dlmethylsulfoxide (stock solutions of IO-100 mM) and 
added to the incubation medium to give final concentrations 
between 0.01 and 300pM. Even at the highest concen- 
trations achieved (0.3%). the solvent had no effect on 
phosphodiesterase activity. 
Protein was determined using the bicinchoninic acid assay 
procedure described by Smith et a/.4’ The inhibitory 
efficiency of xanthines and rolipram on phosphodiesterase 
activity is expressed as percent inhibition of total activity 
(pmol/ml/min), which was determined in the absence of 
these drugs. All assays were performed in triplicate and each 
experiment was repeated at least three times in different 
animals. 
All values are given as mean f S. D. Statistical compari- 
sons of mean valua were made using the Student t-test. 
RESULTS 
Induction of epileptiform activity by 1,3-dipropyl& 
cyclopentylxanthine 
In agreement with previous accounts,” the intrinsic 
firing pattern of CA3 neurons observed in normal 
ACSF was found to be strongly voltage-dependent, 
consisting of either single spike activity at more 
depolarized potentials or burst discharges of two to 
four action potentials riding on top of a small 
depolarizing envelope at more negative potentials. As 
indicated by the high frequency of spontaneously 
occurring postsynaptic potentials, most CA3 neurons 
almost continuously received synaptic input. 
Within 15-20 min of bath application of 
30-100 nM DPCPX, a complete change in neuronal 
discharge behavior was observed (Fig. 1A). The 
normal firing pattern was converted to epileptiform 
activity with rhythmically occurring paroxysmal de- 
polarization shifts (PDSs) generating trains of action 
potentials. Similarly, synaptic stimulation which; 
under control conditions, evoked a single action 
potential, now triggered the discharge of a PDS-like 
event (Fig. IB). The disinhibitory action of DPCPX 
(3GlOOnM) was a consistent finding in all CA3 
neurons tested. In 20 out of 22 cells, DPCPX induced 
epileptiform burst discharges. In the remaining two 
neurons, application of DPCPX led to a depolariz- 
ation of the membrane potential by 3 and 6mV. 
respectively, associated with an increase in input 
resistance and an enhanced firing rate. Once initiated, 
the DPCPX-induced epileptiform activity never 
ceased, even after prolonged (> 3 h) superfusion with 
normal ACSF (Fig. 1). To confirm that the epilepti- 
form activity was generated within the neuronal 
network of area CA3, i.e. independent of external 
inputs from other parts of the hippocampus, exper- 
iments were performed using so-called “CA3 mini- 
slices”, from which all other hippocampal regions had 
been surgically removed (n = 3). When tested under 
these conditions, DPCPX was still able to produce 
the typical PDS-like activity (data not shown). 
Contribution of synaptic mechanisms to the generation 
of 1,3-dipropyl-8-cyclopentylxanthine-induced epilep- 
t&w-m activity 
To study whether the DPCPX-induced burst dis- 
charges represent synaptically mediated or intrinsi- 
cally generated events, the epileptogenic action of the 
xanthine derivative was tested in the presence and 
absence of intact excitatory synaptic transmissron. In 
these experiments (n = 4). EPSPs were blocked by the 
amino-3-hydroxy-5-methyl-4-isoxazolpropionic acid 
receptor antagonist CNQX.’ As illustrated in 
Fig. ZCa-c, bath application of CNQX (10 PM) 
almost completely suppressed excitatory synaptic 
transmission at the mossy fiberCA3 cell synapse 
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Fig. l. Effects of the adenosine A, receptor antagonist DPCPX on the spontaneous and stimulus-evoked 
discharge behavior of CA3 pyramidal cells. A shows parts of a chart record of the membrane potential 
of a CA3 neuron (resting membrane potential: -72  mV; input resistance: 85 Mf~). The downward voltage 
deflections were due to hyperpolarizing current pulses (0.2 nA, 500 ms) which were injected intracellularly 
to monitor input resistance. After the onset of the DPCPX-induced burst discharges, the current pulses 
were only temporarily applied. During electrical stimulation, the membrane potential was hyperpolarized 
to inhibit single spike discharge. In B, samples of postsynaptic responses are depicted on a faster time 
scale. The times given in A correspond to the records shown in B. For illustration, stimulus artifacts were 
removed. The time of stimulation is indicated by arrows. Under control conditions, the stimulus intensity 
was adjusted to evoke one action potential. This stimulus trength was used throughout the experiment. 
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Fig. 2. Suppression of the epileptogenic a tion of DPCPX by the amino-3-hydroxy-5-methyl-4-isoxazol- 
propionic acid receptor antagonist CNQX. In B, a chart record of the membrane potential of a CA3 
neuron (resting membrane potential: -67  mV; input resistance: 95 Mf~) is shown. In A and C, samples 
of both the spontaneous activity (A) and synaptically evoked responses (C) are depicted on faster time 
scales. The records were taken at the points indicated in B by numbers (A) or letters (C), respectively. 
Stimulus artifacts were removed and time of stimulation is signified'by arrowheads. Postsynaptic potentials 
(C) were recorded at  membrane potential of - 80 mV adjusted by hyperpolarizing current injection. Note 
the presence of spontaneous, presumably inhibitory, postsynaptic potentials (Cc,d). In A1, the membrane 
potential was - 58 inV. To test the voltage dependence of the spike discharge, the membrane potential 
was hyperpolarized bycurrent injection to -67 mV (A2) and -87 mV (A3). In contrast to the intrinsically 
generated spiking activity (A l~3) ,  the frequency of DPCPX-induced PDS-like discharges was voltage- 
independent (B4, B5). Note the increase in the amplitude of the slow PDS component upon hyperpolar- 
ization to -87 mV (A4 vs A5). 
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Fig. 3. Failure of the NMDA receptor antagonist D-APV to suppress the epileptogenic a tion of DPCPX. 
A displays a continuous chart record of the membrane potential of a CA3 neuron (resting membrane 
potential: -62 mV; input resistance: 70 M~). Hyperpolarizing current pulses were injected to monitor 
input resistance. They were switched off upon onset of DPCPX-induced burst discharges. The traces in 
B illustrate the stimulus-evoked responses on a faster time scale ( ~l correspond tothe letters in A). The 
synaptic potentials were recorded at a membrane potential of -75mV, which was adjusted by 
hyperpolarizing current injection. Note that, in contrast to control where spikes were suppressed by 
hyperpolarization (Aa and Ab),an increase in membrane potential did not affect he frequency of burst 
discharge in the presence of DPCPX (Ad). 
without substantially altering resting membrane po- 
tential, input resistance or the intrinsic firing pattern 
of CA3 neurons (Fig. 2B). When added to a CNQX- 
containing bathing solution, DPCPX (100 nM) was no 
longer able to induce epileptiform burst discharges. 
However, the A~ receptor antagonist still produced a
remarkable change in the neurons' intrinsic properties. 
As shown in Fig. 2B, DPCPX gradually depolarized 
the membrane potential by about 10 mV and substan- 
tially increased spontaneous firing. Since the pattern of 
intrinsic activity of CA3 neurons is known to be 
strongly voltage-dependent, thefiring rate increasing 
with depolarization and ceasing with yperpolariz- 
ation, 28 we adjusted the membrane potential to several 
holding potentials. As demonstrated bysamples 1-3 in 
Fig. 2A, DPCPX seemed not to alter the typical 
intrinsic discharge behavior of CA3 neurons. Follow- 
ing washout of CNQX and DPCPX (Fig. 2B, wash 
25'), excitatory synaptic transmission fully recovered 
(Fig. 2Cd), whereas the membrane potential remained 
depolarized at a stable level (Fig. 2B). After re-estab- 
lishment of intact excitatory synaptic transmission, 
reapplication of the same concentration of DPCPX 
reliably produced spontaneous and evoked epilepti- 
form discharges in all neurons tested (Fig. 2A4, A5, B, 
Ce). In contrast to the neurons' intrinsic activity, both 
the rate (Fig. 2Be) and the generation of the PDS-like 
events were found to be completely independent ofthe 
neuronal membrane potential (Fig. 2A4, A5; see also 
Fig. 3A). Furthermore, the amplitude of the slow 
depolarization underlying the spike train increased 
with hyperpolarization (Fig. 2A4, A5), suggesting a 
synaptic mechanism of generation. 27 As would be 
expected in this case, the DPCPX-induced epilepti- 
form activity could be reversibly suppressed by CNQX 
(data not shown). 
N-Methyl-D-aspartate independence of 1,3-dipropyl-8- 
cyclopentylxanthine-induced epileptif orm activity 
To find whether induction or maintenance of the 
sustained epileptiform activity observed in the pres- 
ence of DPCPX would require the participation of 
N-methyl-o-aspartate (NMDA) receptors, lices were 
superfused with a bathing solution containing a high 
concentration of the NMDA receptor antagonist o- 
APV. When applied in the presence of D-APV 
(50 p M), DPCPX was still capable of inducing epilep- 
tiform discharges (n = 3). As shown in Fig. 3, both 
spontaneous and stimulus-evoked bursts were ob- 
served following the addition of DPCPX to a D-APV- 
containing medium. Similar to all other experiments, 
the disinhibitory action of DPCPX was irreversible 
within the observation period. 
Postsynaptic actions of 1,3-dipropyl-8-eyclopentyl- 
xanthine 
The DPCPX-induced enhancement of neuronal 
excitability in the absence of excitatory synaptic 
transmission indicated a strong postsynaptic com- 
ponent in the action of the A~ receptor antagonist. To 
investigate the effects of DPCPX on the postsynaptic 
membrane independent ofspike discharges and synap- 
tic transmission, experiments were performed in 
the presence of TTX (0.6#M). When tested under 
these conditions, DPCPX (30-100nM) induced a 
pronounced epolarization of the membrane poten- 
tial, ranging between 14 and 25 mV (19.0 4-4.8 mV, 
n = 6). The onset of the action and the time course of 
the depolarization were similar to the DPCPX-in- 
duced changes observed in TTX-free solution. In three 
out of six neurons, the membrane potential was de- 
polarized up to the threshold for the generation of 
TTX-insensitive, putative calcium spikes (Fig. 4A). 
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Following application of DPCPX, the input resistance 
first slightly increased then substantially declined as the 
membrane potential attained more depolarized values 
(Fig. 4A). This reduction in input resistance was 
probably due to the strong outward rectification i the 
depolarizing direction normally observed in these 
neurons. 1 When kept at control resting membrane 
potential, the input resistance was found to be slightly 
enhanced compared to values determined before appli- 
cation of DPCPX (not shown). As in the previous 
experiments, the DPCPX-induced effects were appar- 
ently irreversible, ven after prolonged (1-3 h) superfu- 
sion with DPCPX-free solution. In the presence of 
TTX, DPCPX did not produce potential changes 
resembling PDS-like events. 
If the postsynaptic depolarizing action of DPCPX 
is due to a release from an inhibitory adenosinergic 
tonus, then enzymatic degradation of endogenous 
adenosine should mimic the effects of DPCPX on the 
membrane potential. Therefore, the action of the 
adenosine degrading enzyme ADA 3~ on membrane 
potential and input resistance was investigated in 
TTX-treated slices (n = 3). Following addition of 
ADA (10 pg/ml) to the ACSF, a depolarization by 
15-22mV was observed in all neurons tested 
(Fig. 4B). Similar to the action of DPCPX, this 
depolarization was associated with a decrease in 
input resistance, due to the outward rectifying prop- 
erties of the cells, and with a low-frequency discharge 
of TTX-insensitive action potentials. Furthermore, 
the effect of the enzyme was apparently irreversible 
within the observation period. 
Effects of 1,3-dipropyl-8-cyclopentylxanthine on phos- 
phodiesterase activity 
To exclude the possibility that the actions of 
DPCPX described so far were due to the inhibition 
of cyclic nucleotide phosphodiesterases, we examined 
the effects of the A] receptor antagonist on the total 
phosphodiesterase ctivity in a homogenate of the rat 
cerebral cortex. In the presence of the non-selective 
phosphodiesterase inhibitor IBMX, a concentration- 
dependent suppression of total phosphodiesterase 
activity was observed (Fig. 5A). At high concen- 
trations (300 # M), IBMX was able to block phospho- 
diesterase activity by up to 90%. The data could be 
fitted with a sigmoid function and a half-maximal 
inhibitory concentration (Ic50) was calculated. When 
1 #M unlabeled cAMP was included in the assay, the 
ICs0 for IBMX was found to be 19.4#M. In the 
presence of 100#M cAMP, the IC50 was 79.8/aM. 
These values agree with those described in the litera- 
ture. 1°'39 The ability of DPCPX to inhibit cAMP 
phosphodiesterase ctivity depended on the substrate 
concentration present in the assay. At a cAMP 
concentration of 1 #M, an increasing blockade of 
phosphodiesterase activity with increasing concen- 
trations of DPCPX was observed (Fig. 5B). However, 
A 
In TTX 
100 nM DPCPX 60 rnin Wash 
1 , I 
ii | IIIL!t IlL JIIIlll[l l  "' 1[I 1 ILl HI]I,L [1,ll 
E'I IL r I l~ I')A#[ll~rm,,,,~,]ll[ ~lrll ii [~lll - - -  
ill i ,  
20 mV 
5 min  
B 10pg/mt ADA 45 min Wash I I 
11 1 ....  lleln I HIIMIflr' 
Fig. 4. Postsynaptic actions f DPCPX and ADA on TTX-treated CA3 pyramidal cells. Chart records 
of the membrane potential from two different CA3 neurons (A: resting membrane potential -66mV; 
input resistance 100 Mf~; B: resting membrane potential -62 mV; input resistance 105 MD). The input 
resistances were monitored by repetitive injection of hyperpolarizing current pulses (0.2 nA, 500 ms). The 
addition of DPCPX (A) or ADA (B) to a TTX-containing bathing solution led to a gradual depolarization 
which eventually reached the threshold for TTX-insensitive spikes (presumably calcium spikes, A). The 
drug-induced depolarizations were irreversible. 
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Fig 5. Action of DPCPX on total CAMP phosphodiesterase activity and electrophysiological effects of 
rolipram. AC show the percentage inhibition of total CAMP phosphodiesterase activity as a function of 
the concentration of IBMX (A), DPCPX (B) and rolipram (C). The enzyme activity was measured in a 
homogenate from rat cerebral cortex using a radiochemical assay. The tests were performed either in the 
presence of 1 pM CAMP (filled circles) or 100 pM CAMP (open circles). The data in A were fitted by a 
sigmoid function. Each point represents the mean value of nine measurements. When error bars are 
lacking, the standard deviation was smaller than the size of the symbol. In D, the effects of rolipram 
(10 PM, 20 min) on stimulus-evoked fEPSPs recorded extracellularly in stratum radiatum of area CA3 
are shown. The held potentials were elicited by stimulation of the mossy fiber pathway using half-maximal 
stimulus intensity. The time point of stimulation is indicated by the stimulus artifact. Each trace represents 
the average of five consecutive r cordings. 
when DPCPX concentrations greater than 10 p M 
were added to the assay, the effect saturated at a 
45-50% inhibition of total phosphodiesterase activity 
(Fig. 5B). In the presence of 100pM CAMP, the 
inhibitory potency of DPCPX was found to be 
significantly smaller. In this case, 30pM DPCPX 
blocked only about 15% of total phosphodiesterase 
activity. At the concentrations used in electrophysio- 
logical experiments (up to lOOnM), DPCPX sup- 
pressed total phosphodiesterase activity by about 
5%, independent of substrate concentration 
(Fig. 5B). The actions of DPCPX on total phospho- 
diesterase activity resembled those of the selective 
phosphodiesterase inhibitor rolipram.” This 
pyrrolidone derivative, which displays no affinity to 
adenosine receptors, selectively inactivates the 
CAMP-specific isozyme (PDE IV”), which is charac- 
terized by a high affinity to CAMP (K,,,: 2pM”). 
Similar to DPCPX, the inhibitory potency of 
rolipram was higher at a substrate concentration of 
1 PM than at 100 PM CAMP, and the effect seemed 
to saturate at about 4&50% inhibition of total 
phosphodiesterase activity (Fig. SC). However, in 
contrast to DPCPX, even at low concentrations 
(0.1-l PM), rolipram blocked 25-30% of the enzyme 
activity (Fig. 5C). 
Since higher concentrations of DPCPX suppressed 
phosphodiesterase activity, we investigated whether 
the phosphodiesterase inhibitor rolipram would 
mimic the effects of DPCPX on fEPSPs recorded 
extracellularly in the stratum radiatum of area CA3.4 
Rolipram was applied at a concentration (10 pM) 
that inhibited about 30% of the total phosphodiester- 
ase activity (Fig. 5C). In all slices tested (n = 4), 
rolipram did not significantly change the amplitude 
and the rise time of the evoked field potentials 
(Fig. 5D). In no case were spontaneous epileptiform 
discharges observed. 
DISCUSSION 
The physiological role of ambient adenosine con- 
centrations in the hippocampal CA3 network was 
investigated using the selective adenosine A, receptor 
antagonist DPCPX. Brief application of the drug 
induced a prolonged disinhibition of CA3 neurons 
572 C. ALZHEIMEK el ai. 
associated with epileptiform burst discharges in more 
than 90% of all neurons tested. Since other, more 
trivial explanations of this phenomenon could be 
excluded-i.e. irreversible A, receptor blockade or 
persistence of the drug in the slice (see Fig. 3 in 
Ref. 4) or side effects of DPCPX on phosphodiester- 
ase activities (Fig. 5)-it appears legitimate to assume 
that the sustained up-regulation of excitability is 
causally linked to the transient suppression of en- 
dogenous adenosinergic inhibition. This notion was 
further sup~rted by the observation that the phos- 
phodiesterase inhibitor rolipram, which lacks 
adenosine receptor affinity, failed to mimic the ac- 
tions of DPCPX (Fig. 5), while the adenosine-degrad- 
ing enzyme ADA produced very similar effects 
(Ref. 7 and Fig. 4). 
~u~pr~ss~u~ of udenos~~e tonus lea& to s~~apti~a~~~ 
mediated burst discharges 
With respect to the origin of the DPCPX-induced 
burst discharges, several observations indicate that 
they were synaptic in nature: while both the shape 
and the frequency of intrinsically generated dis- 
charges of CA3 pyramidal neurons are strictly 
voitage-dependent,27.2a DPCPX-induced bursts oc- 
curred independently of the pre-burst membrane 
potential. Furthermore, the amplitude of the slow 
depolarization underlying the PDS increased with 
hyperpoiarization, indicating that the burst dis- 
charges represented synaptically mediated events re- 
sembling so-called giant EPSPs3’ Consequently, 
DPCPX failed to induce burst discharges when gluta- 
matergic excitatory synaptic transmission was 
blocked by adding the amino-3-hydroxy-5-methyl-4- 
isoxazoipropionic acid receptor antagonist CNQX to 
the bathing solution. Several recent findings from 
other laboratories lend support to the hypothesis that 
the DPCPX-induced epiieptiform activity is mainly 
due to a disinhibition of excitatory transmitter re- 
lease: (1) In a recent quanta1 analysis of giutamatergic 
transmission in the hippocampai slice, Prince and 
Stevens have demonstrated that adenosine reduces 
excitatory neuro~ansmitter release, while relatively 
low concentrations of the non-specific adenosine an- 
tagonist IBMX alone significantly increase the 
amount of excitatory transmitter reieased.4’ There- 
fore, Prince and Stevens have suggested that the 
resting level of endogenous adenosine is sufficient to 
tonically reduce synaptic strength. (2) In or~dnotypic 
slice cultures of the hip~~mpus, adenosine antag- 
onists increased both the frequency and size of spon- 
taneous glutamatergic EPSPs recorded in the 
presence of the GABA, receptor antagonist bicu- 
cuiline.40 (3) In the presence of adenosine antagonists, 
an increase in basal and stimulus-evoked release of 
glutamate from cultured cerebellar granule cells has 
been demonstrated.40 
was observed after application of DPCPX in the 
presence of CNQX and subsequent washout of both 
drugs (Fig. 2). This suggests that the mechanism 
initiating the long-term up-regulation of excitability 
is in some way activity-dependent. It is, for example. 
conceivable that the large calcium influxes that ac- 
company PDS-like discharges might be needed as a 
co-factor in the process that eventually leads to 
self-sustained hyperexcitabiiity.3s This hypothesis is 
also supported by earlier field potential recordings in 
CA1 “minislices”, in which area CA3 was surgically 
removed. In this preparation. iOOnM DPCPX con- 
sistently failed to induce stimulus-evoked or spon- 
taneous epiieptiform activity, but was capable of 
enhancing the amplitude of the population spike by 
40%.1 When using a paired-pulse paradigm, DPCPX 
was found to reduce the facilitation ratio (ampIitude 
of test pulse divided by amplitude of conditioning 
pulse) by about 25% in this preparation, suggesting 
enhanced transmitter release (unpublished obser- 
vation). However, in contrast to its long-lasting effect 
on synaptic transmission in the CA3 network, this 
action of DPCPX in CA1 “minislices” was slowly 
reversible within 60-90 min of drug washout. Again. 
this discrepancy might be ascribed to the fact that the 
initiation of a self-sustained process requires very 
strong excitatory activity as provided by the PDSs 
seen in area CA3, but absent in CA1 ‘“minislices”. In 
addition, regional differences in receptor density or 
location, or in receptor coupling to effector systems, 
could also contribute to the differential action of 
DPCPX in isolated area CA1 vs CA3 of hippo- 
campus. 
Postsynaptic component of adenosine tonus 
Experiments performed in the presence of TTX or 
the non-NMDA glutamate antagonist, CNQX, re- 
vealed an additional strong postsynaptic component 
of endogenous adenosinergic inhibition. On the post- 
synaptic site, removal of the adenosine tonus pro- 
duced a prolonged depolarization of the membrane 
potential accompanied by an increase in spontaneous 
firing (in CNQX) or by an appearance of TTX- 
insensitive, presumed calcium spikes (in TTX). The 
occurrence of TTX-insensitive action potentials at 
depolarized membrane potentials is quite a common 
phenomenon in CNS neurons and can be observed in 
the presence of TTX-containing bath solutions with- 
out any convulsive drug.33 Therefore, it is le~timate 
to conclude that postsynaptic calcium currents under- 
lying these calcium spikes probably contribute to the 
shape and the magnitude of a DPCPX-induced PDS, 
but a facilitation of these currents is unlikely to cause 
the DPCPX-evoked epiieptiform activity. 
Possible mechanisms of‘ sMsta~~ed h.vperexc~tabi~it_y 
after Transient suppression of adenosine tonus 
Interestingly, the induction by DPCPX of sus- As a xanthine derivative, DPCPX might also act 
tained bursting activity seems to require intact gluta- on brain phosphodiesterascs. In fact, measure- 
matergic transmission, since no epiieptiform activity ments of the effects of DPCPX on total CAMP 
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phosphodiesterase activity in rat cerebral cortex re- 
vealed such an action. However, the concentrations 
of DPCPX necessary to produce a significant block 
of phosphodiesterase activity (> 300 nM) are two to 
three orders of magnitude higher than those which 
are sufficient to half-maximally inhibit adenosine A, 
receptors. In binding studies, the K, of DPCPX for 
displacing [3H]cyclohexyladenosine from A, recep- 
tors was found to be 0.46 nM’? and electrophysio- 
logical measurements applying Schild plot analysis 
revealed a ;U, value of 3.3 nM.2 In the el~trophysio- 
logical experiments described in this study, the con- 
centrations of DPCPX never exceeded IOOnM. 
Therefore, we conclude that under the given exper- 
imental conditions, the changes in neuronal proper- 
ties observed following application of DPCPX are 
solely due to a selective blockade of adenosine A, 
receptors. 
Can the functionally significant adenosine tonus 
found in the hippocampal slice preparation represent 
an artifact due to the non-specific accumulation of 
extracellular adenosine resulting from cell damage 
during the dissection and slicing procedure, and the 
slow exchange rate between the core of the slice and 
the surrounding bathing solution? This hypothesis 
has recently been proposed by Thompson et al., who 
failed to observe intrinsic excitatory actions of 
DPCPX in CA3 neurons of an organotypic slice 
culture.52 Although the preparation of slices will 
inevitably be accompanied by an increase in extra- 
cellular adenosine, the foliowing observations indi- 
cate that this increase should remain transient and 
hence not introduce a substantial bias to our study. 
(1) Measurements of ambient adenosine levels in 
slice preparations and in the CNS of intact animals 
have yielded very similar values.“56 (2) Methylxan- 
thines produce a variety of excitatory actions in 
intact animals which are generally believed to be due 
to their antagonism of endogenous adenosine>9 In 
addition, the organotypic slice might not be the 
most suitable preparation to study endogenous 
adenosinergic inhibition. During weeks of culturing, 
slices of CNS tissue are reduced to a monolayer of 
cells. It is thus conceivable that the perfusion system 
required to change bathing solution and apply drugs 
might wash away any endogenously released 
adenosine. Furthermore, the strong recurrent gluta- 
matergic network of area CA3, which mediated the 
DPCPX-triggered, sustained PDS-like discharges in 
our pr~aration, might he less developed and elabor- 
ate in a monolayer of organotypically cultured cells. 
In view of the strong excitatory coupling of CA3 
neurons,3’ it can be argued that the DPCPX-induced 
burst discharges, once initiated, might be sustained 
by reverberating and oscillating excitations so that 
the persistent epileptifo~ activity would represent a 
network phenomenon rather than a dig-indu~ 
alteration in the level of excitability. If so, other 
manipulations leading to seizure activity in area 
CA3 should also be followed by self-sustained 
epileptiform discharges. However, spontaneous 
epileptiform activity induced either by changes in the 
ionic composition of the bathing solution (increased 
~~ssiurn concentration, removal of magnesium 
ions) or by kainate completely ceased after switching 
back to control solution.‘z” In contrast to their 
lacking effect on post-drug spontaneous activity. 
both high extracellular potassium concentration and 
kainate produce a long-lasting disinhibition of the 
mossy fiber-CA3 cell synapse, the initiation of 
which can be prevented by the NMDA receptor 
antagonist o-APV.” This antagonist, however, did 
not block the induction of spontaneous and stimu- 
lus-evoked burst discharges by DPCPX, indicating 
that activation of NMDA receptors is not required 
for the long-term effects of DPCPX to develop. 
How can the transient suppression of an 
adenosine tonus lead to a sustained increase in 
neuronal activity? In central neurons, three different 
A, receptor-mediated actions of adenosine have been 
identified so far, namely activation of a potassium 
conductance,‘,” decrease of a calcium conductance,4’ 
and inhibition of adenylate cyclase.s4 The closure of 
potassium channels which are tonically activated by 
endogenous adenosine might account for the early 
depolarization following application of DPCPX. 
With respect to the long-lasting effects of the A, 
antagonist, facilitation of calcium influx and/or dis- 
inhibition of adenylate cyclase could serve as poss- 
ible mediators that initiate a self-sustained process. 
Rises in cytosolic calcium or CAMP have indeed 
been implicated in long-term increases in hippocam- 
pal excitability.21~35J”~10 
With respect to a putative increase in CAMP, one 
might expect that the drug would simultaneously 
decrease the amplitude of the afterhype~olarizatio~ 
which has previously been demonstrated to accom- 
pany an increase in intracellular cAMP.‘~” This 
effect, however, was not observed following DPCPX 
application, Instead, the drug (100 nM) was found 
to slightly enhance the amplitudes of both the fast 
and slow afterhyperpolarization components (un- 
pub~sh~ observation). This effect might be due to 
the DPCPX-induced increase in input resistance. It 
should be noted, however, that the result of this 
experiment does not rule out an increase in cytosolic 
CAMP, because other substances known to affect 
CAMP levels also failed to decrease afterhyperpolar- 
ization amplitudes in hippocampussO What mechan- 
ism can account for the apparently variable action 
of intracellular CAMP rises on afterhyperpolariza- 
tion amplitudes? A possible explanation would be 
that DPCPX-induced increases in CAMP occur lo- 
cally in restricted compartments of the neuron and 
thus do not affect the conductance mediating the 
a~erh~~olarization, while transmit~rs that 
alter afterh~~ola~zation amplitude via CAMP 
elevation produce rises of this second messenger 
in close proximity to the corresponding ion 
channels. 
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CONCLUSIONS 
Our results indicate that endogenous adenosine 
acting on A, receptors exerts a strong control of 
both the pre- and postsynaptic excitability in the 
hippocampal CA3 region. A transient suppression 
of the inhibitory tonus causes sustained epilepti- 
form burst discharges that are synaptic in nature, 
but do not require initial NMDA receptor activation 
to persist. This long-lasting disinhibition most 
determine how and to what extent the different 
A, receptor-mediated pathways contribute to the 
long-term effects observed after a transient removal 
of endogenous adenosinergic inhibition. Further 
research will be required to explain the delicate 
relationship between adenosine tonus and 
neuronal excitability in terms of its molecular 
machinery. 
likely involves one or both of the signaling pathways 
modulated by endogenous adenosine, 
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